Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 15;181(4):246-50.
doi: 10.1093/aje/kwv001. Epub 2015 Feb 5.

Risk

Stephen R Cole, Michael G Hudgens, M Alan Brookhart, Daniel Westreich

Risk

Stephen R Cole et al. Am J Epidemiol. .

Abstract

The epidemiologist primarily studies transitions between states of health and disease. The purpose of the present article is to define a foundational parameter for such studies, namely risk. We begin simply and build to the setting in which there is more than 1 event type (i.e., competing risks or competing events), as well as more than 1 treatment or exposure level of interest. In the presence of competing events, the risks are a set of counterfactual cumulative incidence functions for each treatment. These risks can be depicted visually and summarized numerically. We use an example from the study of human immunodeficiency virus to illustrate concepts.

Keywords: causal inference; cohort study; semi-Bayes method; semiparametric inference; survival analysis.

PubMed Disclaimer

References

    1. Westreich D, Pence BW, Turner AN. In populo. Epidemiology. 2010;21(1):152–153. - PMC - PubMed
    1. Rothman KJ, Greenland S, Lash T. Modern Epidemiology. 3rd ed. New York, NY: Lippincott-Raven; 2008.
    1. Westreich D, Cole SR, Young JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31(18):2000–2009. - PMC - PubMed
    1. Cole SR, Lau B, Eron JJ, et al. Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol. 2015;181(4):238–245. - PMC - PubMed
    1. Robins JM. Confidence intervals for causal parameters. Stat Med. 1988;7(7):773–785. - PubMed

Publication types

Substances